Asim Siddiqui
Chief Tech/Sci/R&D Officer chez SEER, INC.
Profil
Asim Siddiqui is currently working as the Senior VP-Research & Tech Development at Seer, Inc. (California).
Previously, he held positions such as Director-Bioinformatics at Life Technologies, Inc. from 2008 to 2013, Vice President-Research at Sirius Genomics, Inc., Bioinformatics Group Leader at BC Cancer Agency Genome Sciences Centre, and Vice President-Products Development at Natera, Inc. from 2013 to 2015.
From 2015 to 2019, he served as the Chief Technology Officer at NuMedii, Inc. Dr. Siddiqui obtained a doctorate degree from the University of Oxford and an undergraduate degree from the University of Cambridge.
Postes actifs de Asim Siddiqui
| Sociétés | Poste | Début |
|---|---|---|
| SEER, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Asim Siddiqui
| Sociétés | Poste | Fin |
|---|---|---|
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| NATERA, INC. | Corporate Officer/Principal | 01/06/2015 |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | 01/04/2013 |
BC Cancer Agency Genome Sciences Centre
 BC Cancer Agency Genome Sciences Centre Hospital/Nursing ManagementHealth Services BC Cancer Agency Genome Sciences Centre provides cancer therapy services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - |
Formation de Asim Siddiqui
| University of Oxford | Doctorate Degree |
| University of Cambridge | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NATERA, INC. | Health Technology |
| SEER, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |
BC Cancer Agency Genome Sciences Centre
BC Cancer Agency Genome Sciences Centre Hospital/Nursing ManagementHealth Services BC Cancer Agency Genome Sciences Centre provides cancer therapy services. The company is headquartered in Vancouver, Canada. | Health Services |
